Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 66 member 1 like, pseudogene (SLC66A1LP) is classified as a **pseudogene**, meaning it is a segment of DNA that is similar to a gene but is non-functional and does not produce a functional protein. Although it is predicted (based on homology) to potentially encode a lysine transmembrane transporter associated with the lysosomal membrane, current scientific consensus classifies it as not encoding an active protein or a functional drug target[1][2]. No validated biological functions, disease associations, or clinical drug interactions are reported. SLC66A1LP is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 66 member 1 like, pseudogene (SLC66A1LP).